Doxil and Herceptin

Options
luvmyself
luvmyself Member Posts: 146
edited June 2014 in HER2+ (Positive) Breast Cancer

So I'm getting ready to start this combo next week and am wondering if anyone else has had these 2 together.   Thanks Jill

· Share on FacebookShare on Twitter

Comments

  • lovemygarden
    lovemygarden Member Posts: 342
    edited October 2010

    Doxil = trade name for doxirubicin. It's an anthracycline, like Adriamycin

    Frankly I've never heard of just AH ( or just DH). In fact many oncs are moving away from combining anthracyclines and Herceptin because of the increased heart risk. Have you had a baseline MUGA or echocardiogram yet?

    · Share on FacebookShare on Twitter
  • luvmyself
    luvmyself Member Posts: 146
    edited October 2010

    love- I had a muga scan yesterday. My onc said he will monitor me closely and said we should be able to see if it is working after 2 treatments. I had TAC followed by Herceptin 5 years ago. I just pray this treatment does the trick.  Jill

    · Share on FacebookShare on Twitter
  • lovemygarden
    lovemygarden Member Posts: 342
    edited October 2010

    Ah, good. I didn't realize you'd already had TAC/H before (thought this was your first go-round!). To be honest I was a little puzzled at them using DH for node-negative Stage II right off the bat like that, since most newbies seem to be given either Taxotere/C/H or Taxol/H nowadays. 

    Glad you're getting the MUGAs too, instead of just an echo. Sounds like your onc is cautious which is great.

    Best of luck and good wishes to you on the new regimen!  

    · Share on FacebookShare on Twitter
  • luvmyself
    luvmyself Member Posts: 146
    edited August 2013

    thanks Love- I had my first treatment today and all went well. (so far). I decided to do the herceptin weekly instead of every 3 weeks. The onc nurse thought that having a lower dose weekly may help to handle the se's of the Doxil a little easier. Muga scan was good 63%.

    Thanks for the well wishes :)

    Jill

    · Share on FacebookShare on Twitter

Categories